Search
25/01/2024
RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine
del Rincón, CR, Gonzalez-Martinez, A, Quintas, S, García-Azorín, D, Lázaro, IF, Guerrero-Peral, AL, Osorio, YG, Santos-Lasaosa, S, Oria, CG, Rodríguez, NS, Díez, FI, Iñiguez, AE, Luque, SG, Huerta-Villanueva, M, Díaz, SC, Muñoz-Vendrell, A, Ros, AL, Sánchez-Soblechero, A, Juanes, FV, Kortazar-Zubizarreta, I, Echeverria, A, Rodríguez-Vico, J, Sánchez, AJ, Garcia, AG, Sánchez-Mateos, NM, Belvis, R, Pérez, MPN, García-Monco, JC, Escudero, MRA, Montes, N, Gago-Veiga, AB. RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine. EUROPEAN JOURNAL OF NEUROLOGY. 2024; 31(4)DOI:10.1111/ene.16203. PMID:38270379. IF:3.900(Q1/3D).
16/01/2024
New therapeutic era for migraine attacks with recently approved monoclonal antibodies, ditans and gepants
Mínguez-Olaondo, A, López-Bravo, A, Quintas, S, Nieves-Castellanos, C, Layos-Romero, A, Belvís, R, Irimia, P, Díaz-Insa, S. New therapeutic era for migraine attacks with recently approved monoclonal antibodies, ditans and gepants. REVISTA DE NEUROLOGIA. 2024; 78(2)DOI:10.33588/rn.7802.2023176. PMID:38223948. IF:0.800(Q4/9D).
19/12/2023
Medical help-seeking intentions among patients with early Alzheimer's disease
Villarejo-Galende, A, García-Arcelay, E, Piñol-Ripoll, G, del Olmo-Rodríguez, A, Viñuela, F, Boada, M, Franco-Macías, E, de la Peña, AI, Riverol, M, Puig-Pijoan, A, Abizanda-Soler, P, Arroyo, R, Baquero-Toledo, M, Feria-Vilar, I, Balasa, M, Berbel, A, Rodríguez-Rodríguez, E, Vieira-Campos, A, Garcia-Ribas, G, Rodrigo-Herrero, S, Lleó, A, Maurino, J. Medical help-seeking intentions among patients with early Alzheimer's disease. Frontiers in Psychiatry. 2023; 14DOI:10.3389/fpsyt.2023.1290002. PMID:38173708. IF:3.200(Q2/4D).
15/12/2023
Empathy as a crucial skill in disrupting disparities in global brain health
Fitri, FI, Lage, C, Mollayeva, T, Santamaria-Garcia, H, Chan, MLS, Cominetti, MR, Daria, T, Fallon, G, Gately, D, Gichu, M, Gimenez, S, Zuniga, RG, Hadad, R, Hill-Jarrett, T, O'Kelly, M, Martinez, L, Modjaji, P, Ngcobo, N, Nowak, R, Ogbuagu, C, Roche, M, Aguzzoli, CS, Shin, SY, Smith, E, Yoseph, SA, Zewde, Y, Ayhan, Y. Empathy as a crucial skill in disrupting disparities in global brain health. Frontiers in Neurology. 2023; 14DOI:10.3389/fneur.2023.1189143. PMID:38162446. IF:2.700(Q2/4D).
12/12/2023
Down Syndrome in a New Era for Alzheimer Disease
Rafii, MS, Fortea, J. Down Syndrome in a New Era for Alzheimer Disease. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2023; 330(22)DOI:10.1001/jama.2023.22924. PMID:37991807. IF:63.500(Q1/1D).
05/12/2023
Association of Blood-Based DNA Methylation Markers With Late-Onset Alzheimer Disease
Acha, B, Corroza, J, de Gordoa, JSR, Cabello, C, Robles, M, Mendez-López, I, Macías, M, Zueco, S, Roldan, M, Urdánoz-Casado, A, Jericó, I, Erro, ME, Alcolea, D, Lleo, A, Blanco-Luquin, I, Mendioroz, M. Association of Blood-Based DNA Methylation Markers With Late-Onset Alzheimer Disease. NEUROLOGY. 2023; 101(23)DOI:10.1212/WNL.0000000000207865. PMID:37827850. IF:8.400(Q1/1D).
01/12/2023
Proteomic comparison between non-purified cerebrospinal fluid and cerebrospinal fluid-derived extracellular vesicles from patients with Alzheimer's, Parkinson's and Lewy body dementia
Hirschberg, Y, Valle-Tamayo, N, Dols-Icardo, O, Engelborghs, S, Buelens, B, Vandenbroucke, RE, Vermeiren, Y, Boonen, K, Mertens, I. Proteomic comparison between non-purified cerebrospinal fluid and cerebrospinal fluid-derived extracellular vesicles from patients with Alzheimer's, Parkinson's and Lewy body dementia. Journal of Extracellular Vesicles. 2023; 12(12)DOI:10.1002/jev2.12383. PMID:38082559. IF:15.500(Q1/1D).
03/08/2023
Prevalence of treated patients with Alzheimer's disease: current trends and COVID-19 impact
Olazarán J., Carnero-Pardo C., Fortea J., Sánchez-Juan P., García-Ribas G., Vinuela, F, Martínez-Lage P., Boada M.. Prevalence of treated patients with Alzheimer's disease: current trends and COVID-19 impact. Alzheimers Research & Therapy. 2023; 15(1)DOI:10.1186/s13195-023-01271-0. PMID:37537656. IF:8.000(Q1/1D).
01/08/2023
Cortical microstructural changes predict tau accumulation and episodic memory decline in older adults harboring amyloid
Gagliardi, G, Rodriguez-Vieitez, E, Montal, V, Sepulcre, J, Diez, I, Lois, C, Hanseeuw, B, Schultz, AP, Properzi, MJ, Papp, KV, Marshall, GA, Fortea, J, Johnson, KA, Sperling, RA, Vannini, P. Cortical microstructural changes predict tau accumulation and episodic memory decline in older adults harboring amyloid. Communications Medicine. 2023; 3(1)DOI:10.1038/s43856-023-00324-7. PMID:37528163. IF:(Q/D).
26/07/2023
Thimet oligopeptidase as a potential CSF biomarker for Alzheimer's disease: A cross-platform validation study
Hok-A-Hin, YS, Bolsewig, K, Ruiters, DN, Lleo, A, Alcolea, D, Lemstra, AW, van der Flier, WM, Teunissen, CE, del Campo, M. Thimet oligopeptidase as a potential CSF biomarker for Alzheimer's disease: A cross-platform validation study. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2023; 15(3)DOI:10.1002/dad2.12456. PMID:37502019. IF:(Q/D).
25/07/2023
Blood Biomarkers in Neurodegenerative Diseases Implications for the Clinical Neurologist
Alcolea, D, Beeri, MS, Rojas, JC, Gardner, RC, Lleo, A. Blood Biomarkers in Neurodegenerative Diseases Implications for the Clinical Neurologist. NEUROLOGY. 2023; 101(4)DOI:10.1212/WNL.0000000000207193. PMID:36878698. IF:8.400(Q1/1D).
31/05/2023
Brain glucose metabolism and gray matter volume in retired professional soccer players: a cross-sectional [F-18]FDG-PET/MRI study
Aranha M.R., Coutinho A.M., Carneiro, CD, Pastorello B.F., Studart-Neto A., Guariglia C.C., Tsunemi M.H., Moreira, ELS, Ianof J.N., Anghinah R., Nitrini R., Cerri G.G., Fortea J., Buchpiguel C.A., Leite C.C.. Brain glucose metabolism and gray matter volume in retired professional soccer players: a cross-sectional [F-18]FDG-PET/MRI study. ARQUIVOS DE NEURO-PSIQUIATRIA. 2023; 81(05)DOI:10.1055/s-0043-1768666. PMID:37257463. IF:1.000(Q4/8D).
25/05/2023
Burnout among neurologists caring for patients with cognitive disorders in Spain
Fortea, J, Garcia-Arcelay, E, Garcia-Ribas, G, Canal, N, Maurino, J. Burnout among neurologists caring for patients with cognitive disorders in Spain. PLoS One. 2023; 18(5)DOI:10.1371/journal.pone.0286129. PMID:37228146. IF:2.900(Q1/3D).
05/05/2023
Cognitive and Motor Decline in Dementia with Lewy Bodies and Parkinson's Disease Dementia
Gonzalez, MC, Tovar-Rios, DA, Alves, G, Dalen, I, Williams-Gray, CH, Camacho, M, Forsgren, L, Backstrom, D, Lawson, RA, Macleod, AD, Counsell, CE, Paquet, C, DeLena, C, D'Antonio, F, Pilotto, A, Padovani, A, Blanc, F, Falup-Pecurariu, C, Lewis, SJG, Rejdak, K, Papuc, E, Hort, J, Nedelska, Z, O'Brien, J, Bonanni, L, Marquie, M, Boada, M, Pytel, V, Abdelnour, C, Alcolea, D, Beyer, K, Tysnes, OB, Aarsland, D, Maple-Grodem, J. Cognitive and Motor Decline in Dementia with Lewy Bodies and Parkinson's Disease Dementia. Movement Disorders Clinical Practice. 2023; 10(6)DOI:10.1002/mdc3.13752. PMID:37332651. IF:2.600(Q2/5D).
24/04/2023
Effects of storage conditions on the stability of blood-based markers for the diagnosis of Alzheimer's disease
Mansilla, A, Canyelles, M, Ferrer, R, Arranz, J, Rodriguez-Baz, I, Zhu, N, Rubio-Guerra, S, El Bounasri, S, Sanchez, O, Torres, S, Fortea, J, Lleo, A, Alcolea, D, Tondo, M. Effects of storage conditions on the stability of blood-based markers for the diagnosis of Alzheimer's disease. CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2023; 61(9)DOI:10.1515/cclm-2023-0245. PMID:37083158. IF:3.800(Q1/2D).
01/04/2023
Plasma and cerebrospinal fluid glial fibrillary acidic protein levels in adults with Down syndrome: a longitudinal cohort study
Montoliu-Gaya, L, Alcolea, D, Ashton, NJ, Pegueroles, J, Levin, J, Bosch, B, Lantero-Rodriguez, J, Carmona-Iragui, M, Wagemann, O, Balasa, M, Kac, PR, Barroeta, I, Llado, A, Brum, WS, Videla, L, Gonzalez-Ortiz, F, Benejam, B, Martinez, JJA, Karikari, TK, Nubling, G, Bejanin, A, Benedet, AL, Blesa, R, Lleo, A, Blennow, K, Sanchez-Valle, R, Zetterberg, H, Fortea, J. Plasma and cerebrospinal fluid glial fibrillary acidic protein levels in adults with Down syndrome: a longitudinal cohort study. EBioMedicine. 2023; 90DOI:10.1016/j.ebiom.2023.104547. PMID:37002988. IF:9.700(Q1/1D).
13/03/2023
Purpose in life promotes resilience to age-related brain burden in middle-aged adults
Abellaneda-Perez, K, Cattaneo, G, Cabello-Toscano, M, Solana-Sanchez, J, Mulet-Pons, L, Vaque-Alcazar, L, Perellon-Alfonso, R, Sole-Padulles, C, Bargallo, N, Tormos, JM, Pascual-Leone, A, Bartres-Faz, D. Purpose in life promotes resilience to age-related brain burden in middle-aged adults. Alzheimers Research & Therapy. 2023; 15(1)DOI:10.1186/s13195-023-01198-6. PMID:36915148. IF:8.000(Q1/1D).
25/01/2023
Reduced Number of Thymoma CTLA4-Positive Cells Is Associated With a Higher Probability of Developing Myasthenia Gravis
Álvarez-Velasco R., Dols-Icardo O., El Bounasri S., López-Vilaró L., Trujillo J.C., Reyes-Leiva D., Suárez-Calvet X., Cortés-Vicente E., Illa I., Gallardo E.. Reduced Number of Thymoma CTLA4-Positive Cells Is Associated With a Higher Probability of Developing Myasthenia Gravis. Neurology-Neuroimmunology & Neuroinflammation. 2023; 10(2)DOI:10.1212/NXI.0000000000200085. PMID:36697230. IF:8.300(Q1/1D).
01/01/2023
Caregiver knowledge of obstructive sleep apnoea in Down syndrome
Giménez S., Tapia I.E., Fortea J., Levedowski D., Osorio R., Hendrix J., Hillerstrom H.. Caregiver knowledge of obstructive sleep apnoea in Down syndrome. JOURNAL OF INTELLECTUAL DISABILITY RESEARCH. 2023; 67(1)DOI:10.1111/jir.12990. PMID:36416001. IF:2.100(Q1/2D).
01/01/2023
Lessons from Down syndrome and autosomal dominant Alzheimer's disease
Fortea J., Quiroz Y.T., Ryan N.S.. Lessons from Down syndrome and autosomal dominant Alzheimer's disease. LANCET NEUROLOGY. 2023; 22(1)DOI:10.1016/S1474-4422(22)00437-9. PMID:36517171. IF:46.600(Q1/1D).
01/01/2023
Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8)
Tesi N., Grenier-Boley B., Andrade V., Jansen I.E., Pedersen N.L., Stringa N., Zettergren A., Antonell A., Tankard R.M., Bis J.C., Sims R., Bellenguez C., González-Perez A., Macías J., Cervera-Carles L., Moreno F., Huerto Vilas R., García-Madrona S., Ullgren A., Naj A.C., Lemstra A.W., Pérez-Cordón A., Benussi A., Padovani A., Squassina A., de Mendonça A., Arias Pastor A., Kok A.A.L., Meggy A., Pastor A.B., Corma-Gómez A., Sanabria Á., DeStefano A.L., Schneider A., Haapasalo A., Kinhult Ståhlbom A., Tybjærg-Hansen A., Hartmann A.M., Spottke A., Borroni B., Arosio B., Nacmias B., Nordestgaard B.G., Kunkle B.W., Charbonnier C., Masullo C., Martínez Rodríguez C., Muñoz-Fernandez C., Dufouil C., Graff C., Ferreira C.B., Chillotti C., Reynolds C.A., Fenoglio C., Van Broeckhoven C., Clark C., Pisanu C., Satizabal C.L., Holmes C., Aarsland D., Rujescu D., Alcolea D., Galimberti D., Wallon D., Seripa D., Grünblatt E., Dardiotis E., Düzel E., Scarpini E., Conti E., Rubino E., Gelpi E., Rodriguez-Rodriguez E., Duron E., Boerwinkle E., Ferri E., Tagliavini F., Küçükali F., Pasquier F., Sanchez-Garcia F., Mangialasche F., Jessen F., Nicolas G., Selbæk G., Chêne G., Hadjigeorgiou G., Rossi G., Spalletta G., Giaccone G., Grande G., Binetti G., Papenberg G., Hampel H., Bailly H., Zetterberg H., Soininen H., Karlsson I.K., Alvarez I., Appollonio I., Giegling I., Skoog I., Saltvedt I., Rainero I., Rosas Allende I., Hort J., Diehl-Schmid J., Van Dongen J., Vidal J.-S., Lehtisalo J., Wiltfang J., Thomassen J.Q., Kornhuber J., Haines J.L., Vogelgsang J., Popp J., Deckert J., Buerger K., Morgan K., Fließbach K., Sleegers K., Molina-Porcel L., Kilander L., Weinhold L., Farrer L.A., Wang L.-S., Kleineidam L., Farotti L., Parnetti L., Tremolizzo L., Hausner L., Benussi L., Froelich L., Ikram M.A., Deniz-Naranjo M.C., Tsolaki M., Löwenmark M., Hulsman M., Spallazzi M., Pericak-Vance M.A., Esiri M., Bernal Sánchez-Arjona M., Dalmasso M.C., Martínez-Larrad M.T., Arcaro M., Nöthen M.M., Fernández-Fuertes M., Dichgans M., Ingelsson M., Herrmann M.J., Scherer M., Vyhnalek M., Kosmidis M.H., Yannakoulia M., Schmid M., Ewers M., Heneka M.T., Wagner M., Scamosci M., Kivipelto M., Hiltunen M., Zulaica M., Fornage M., Roberto N., van Schoor N.M., Seidu N.M., Banaj N., Armstrong N.J., Scarmeas N., Scherbaum N., Goldhardt O., Hanon O., Peters O., Skrobot O.A., Quenez O., Lerch O., Bossù P., Caffarra P., Dionigi Rossi P., Sakka P., Mecocci P., Hoffmann P., Holmans P.A., Fischer P., Riederer P., Yang Q., Marshall R., Kalaria R.N., Mayeux R., Vandenberghe R., Cecchetti R., Ghidoni R., Frikke-Schmidt R., Sorbi S., Hägg S., Engelborghs S., Helisalmi S., Botne Sando S., Kern S., Archetti S., Boschi S., Fostinelli S., Mendoza S., Mead S., Ciccone S., Djurovic S., Heilmann-Heimbach S., Riedel-Heller S., Kuulasmaa T., Lebouvier T., Polak T., Ngandu T., Grimmer T., Bessi V., Escott-Price V., Giedraitis V., Deramecourt V., Maier W., Jian X., Pijnenburg Y.A.L., Smith A.D., Saenz A., Bizzarro A., Lauria A., Vacca A., Solomon A., Anastasiou A., Richardson A., Boland A., Koivisto A., Daniele A., Greco A., Marianthi A., McGuinness B., Fin B., Ferrari C., Custodero C., Ferrarese C., Ingino C., Mangone C., Reyes Toso C., Cuesta C., Muchnik C., Joachim C., Ortiz C., Besse C., Johansson C., Zoia C.P., Laske C., Anastasiou C., Palacio D.L., Politis D.G., Janowitz D., Craig D., Mann D.M., Neary D., Jürgen D., Daian D., Belezhanska D., Kohler E., Castaño E.M., Koutsouraki E., Chipi E., De Roeck E., Costantini E., Vardy E.R.L.C., Roveta F., Piras F., Prestia F.A., Assogna F., Salani F., Sala G., Lacidogna G., Novack G., Wilcock G., Thonberg H., Kölsch H., Weber H., Boecker H., Etchepareborda I., Piaceri I., Tuomilehto J., Lindström J., Laczo J., Johnston J., Deleuze J.-F., Harris J., Schott J.M., Priller J., Bacha J.I., Snowden J., Lisso J., Mihova K.Y., Traykov L., Morelli L., Brusco L.I., Rainer M., Takalo M., Bjerke M., Del Zompo M., Serpente M., Sanchez Abalos M., Rios M., Peltonen M., Herrman M.J., Kohler M., Rojo M., Jones M., Orsini M., Medel N., Olivar N., Fox N.C., Salvadori N., Hooper N.M., Galeano P., Solis P., Bastiani P., Passmore P., Heun R., Antikainen R., Olaso R., Perneczky R., Germani S., Love S., Mehrabian S., Bagnoli S., Kochen S., Andreoni S., Teipel S., Todd S., Pickering-Brown S., Natunen T., Tegos T., Laatikainen T., Strandberg T., Polvikoski T.M., Matoska V., Ciullo V., Cores V., Solfrizzi V., Lisetti V., Sevillano Z., Abdelnour C., Aguilera N., Alarcon E., Alegret M., Benaque A., Buendia M., Cañabate P., Carracedo A., Corbatón-Anchuelo A., Diego S., Espinosa A., Gailhajenet A., García-González P., Gil S., Guitart M., González-Pérez A., Hernández I., Ibarria M., Lafuente A., Macias J., Maroñas O., Martín E., Martínez M.T., Mauleón A., Montrreal L., Moreno-Grau S., Moreno M., Ortega G., Pancho A., Pelejá E., Pérez-Cordon A., Pineda J.A., Preckler S., Quintela I., Rosende-Roca M., Sanabria A., Serrano-Rios M., Sotolongo-Grau O., Valero S., Vargas L., Adarmes-Gómez A.D., Alarcón-Martín E., Alonso M.D., Álvarez I., Amer-Ferrer G., Antequera M., Antúnez C., Baquero M., Bernal M., Blesa R., Buiza-Rueda D., Burguera J.A., Calero M., Carrillo F., Carrión-Claro M., Casajeros M.J., Cruz-Gamero J.M., de Pancorbo M.M., de Rojas I., del Ser T., Diez-Fairen M., Escuela R., Garrote-Espina L., Fortea J., Franco-Macías E., Frank-García A., Garcia Madrona S., Gómez-Garre P., Hevilla S., Jesús S., Labrador Espinosa M.A., Lage C., Legaz A., López-García S., Macias-García D., Manzanares S., Marín M., Marín-Muñoz J., Marín T., Martín Montes A., Martínez B., Martínez C., Martínez V., Martínez-Lage Álvarez P., Mendioroz Iriarte M., Menéndez-González M., Molinuevo J.L., Pérez Tur J., Periñán-Tocino T., Pineda-Sanchez R., Rábano A., Real de Asúa D., Rodrigo S., Rodríguez-Rodríguez E., Royo J.L., Sanchez del Valle Díaz R., Sastre I., Vicente M.P., Vigo-Ortega R., Vivancos L., Macleod C., McCracken C., Brayne C., Bresner C., Grozeva D., Bellou E., Sommerville E.W., Matthews F., Leonenko G., Menzies G., Windle G., Harwood J., Phillips J., Bennett K., Luckuck L., Clare L., Woods R., Saad S., Burholt V., Rongve A., Kehoe P.G., Garcia-Ribas G., Sánchez-Juan P., Pastor P., Pérez-Tur J., Piñol-Ripoll G., Lopez de Munain A., García-Alberca J.M., Bullido M.J., Álvarez V., Lleó A., Real L.M., Mir P., Medina M., Scheltens P., Holstege H., Marquié M., Sáez M.E., Carracedo Á., Amouyel P., Schellenberg G.D., Williams J., Seshadri S., van Duijn C.M., Mather K.A., Sánchez-Valle R., Serrano-Ríos M., Orellana A., Tárraga L., Blennow K., Huisman M., Andreassen O.A., Posthuma D., Clarimón J., Boada M., van der Flier W.M., Ramirez A., Lambert J.-C., van der Lee S.J., Ruiz A., EADB contributors, IGAP (ADGC, CHARGE, EADI, GERAD), PGC-ALZ consortia. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8). Nature Communications. 2023; 14(1)DOI:10.1038/s41467-023-36192-x. PMID:36759603. IF:14.700(Q1/1D).
01/01/2023
Neuroinflammation-Related Proteins NOD2 and Spp1 Are Abnormally Upregulated in Amyotrophic Lateral Sclerosis
de Luna N., Carbayo Á., Dols-Icardo O., Turon-Sans J., Reyes-Leiva D., Illan-Gala I., Jericó I., Pagola-Lorz I., Lleixà C., Querol L., Rubio-Guerra S., Alcolea D., Fortea J., Lleó A., Cortés-Vicente E., Rojas-Garcia R.. Neuroinflammation-Related Proteins NOD2 and Spp1 Are Abnormally Upregulated in Amyotrophic Lateral Sclerosis. Neurology-Neuroimmunology & Neuroinflammation. 2023; 10(2)DOI:10.1212/NXI.0000000000200072. PMID:36460480. IF:8.300(Q1/1D).
01/01/2023
Prevalence, Timing, and Network Localization of Emergent Visual Creativity in Frontotemporal Dementia
Friedberg A., Pasquini L., Diggs R., Glaubitz E.A., Lopez L., Illán-Gala I., Iaccarino L., La Joie R., Mundada N., Knudtson M., Neylan K., Brown J., Allen I.E., Rankin K.P., Bonham L.W., Yokoyama J.S., Ramos E.M., Geschwind D.H., Spina S., Grinberg L.T., Miller Z.A., Kramer J.H., Rosen H., Gorno-Tempini M.L., Rabinovici G., Seeley W.W., Miller B.L.. Prevalence, Timing, and Network Localization of Emergent Visual Creativity in Frontotemporal Dementia. JAMA Neurology. 2023; 80(4)DOI:10.1001/jamaneurol.2023.0001. PMID:36848111. IF:20.900(Q1/1D).
01/01/2023
Attitudes of Neurologists Toward the Use of Biomarkers in the Diagnosis of Early Alzheimer's Disease
Fortea, J, Garcia-Arcelay, E, Terrancle, A, Galvez, B, Diez-Carreras, V, Rebollo, P, Maurino, J, Garcia-Ribas, G. Attitudes of Neurologists Toward the Use of Biomarkers in the Diagnosis of Early Alzheimer's Disease. JOURNAL OF ALZHEIMERS DISEASE. 2023; 93(1)DOI:10.3233/JAD-221160. PMID:36970902. IF:3.400(Q2/4D).
01/01/2023
Full-Length SMN Transcript in Extracellular Vesicles as Biomarker in Individuals with Spinal Muscular Atrophy Type 2 Treated with Nusinersen
Trifunov S., Natera-De Benito D., Carrera-García L., Codina A., Expósito-Escudero J., Ortez C., Medina J., Alcala, ST, Bernal S., Alias L., Badosa C., Balsells S., Alcolea D., Nascimento A., Jimenez-Mallebrera C.. Full-Length SMN Transcript in Extracellular Vesicles as Biomarker in Individuals with Spinal Muscular Atrophy Type 2 Treated with Nusinersen. Journal Of Neuromuscular Diseases. 2023; 10(4)DOI:10.3233/JND-230012. PMID:37038823. IF:3.200(Q2/3D).
01/01/2023
Innovating Therapies for Down Syndrome: An International Virtual Conference of the T21 Research Society
Hamlett E.D., Flores-Aguilar L., Handen B., Potier M.-C., Granholm A.-C., Sherman S., Puig V., Santoro J.D., Carmona-Iragui M., Rebillat A.-S., Head E., Strydom A., Busciglio J.. Innovating Therapies for Down Syndrome: An International Virtual Conference of the T21 Research Society. Molecular Syndromology. 2023; 14(2)DOI:10.1159/000526021. PMID:37064334. IF:0.900(Q4/10D).
01/01/2023
Multifocal Transcranial Direct Current Stimulation in Primary Progressive Aphasia Does Not Provide a Clinical Benefit Over Speech Therapy
Borrego-Écija S., Montagut N., Martín-Trias P., Vaqué-Alcázar L., Illán-Gala I., Balasa M., Lladó A., Casanova-Mollà J., Bargalló N., Valls-Solé J., Lleó A., Bartrés-Faz D., Sánchez-Valle R.. Multifocal Transcranial Direct Current Stimulation in Primary Progressive Aphasia Does Not Provide a Clinical Benefit Over Speech Therapy. JOURNAL OF ALZHEIMERS DISEASE. 2023; 93(3)DOI:10.3233/JAD-230069. PMID:37182884. IF:3.400(Q2/4D).
01/01/2023
Compounded inequality: racial disparity and Down syndrome
McGlinchey E., Iulita M.F., Fortea J.. Compounded inequality: racial disparity and Down syndrome. Lancet Public Health. 2023; 8(11)DOI:10.1016/S2468-2667(23)00213-X. PMID:. IF:(Q/D).
01/01/2023
Bilingual Primary Progressive Aphasia: A Scoping Review of Assessment and Treatment Practices
Grasso, SM, Rodríguez, CAW, Colomer, NM, Kiderle, SKM, Sáanchez-Valle, R, Santos, MAS. Bilingual Primary Progressive Aphasia: A Scoping Review of Assessment and Treatment Practices. JOURNAL OF ALZHEIMERS DISEASE. 2023; 96(4)DOI:10.3233/JAD-230673. PMID:37980666. IF:3.400(Q2/4D).
01/12/2022
Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's disease
Holstege, H, Hulsman, M, Charbonnier, C, Grenier-Boley, B, Quenez, O, Grozeva, D, van Rooij, JGJ, Sims, R, Ahmad, S, Amin, N, Norsworthy, PJ, Dols-Icardo, O, Hummerich, H, Kawalia, A, Amouyel, P, Beecham, GW, Berr, C, Bis, JC, Boland, A, Bossu, P, Bouwman, F, Bras, J, Campion, D, Cochran, JN, Daniele, A, Dartigues, JF, Debette, S, Deleuze, JF, Denning, N, DeStefano, AL, Farrer, LA, Fernandez, MV, Fox, NC, Galimberti, D, Genin, E, Gille, JJP, Le Guen, Y, Guerreiro, R, Haines, JL, Holmes, C, Ikram, MA, Ikram, MK, Jansen, IE, Kraaij, R, Lathrop, M, Lemstra, AW, Lleo, A, Luckcuck, L, Mannens, MMAM, Marshall, R, Martin, ER, Masullo, C, Mayeux, R, Mecocci, P, Meggy, A, Mol, MO, Morgan, K, Myers, RM, Nacmias, B, Naj, AC, Napolioni, V, Pasquier, F, Pastor, P, Pericak-Vance, MA, Raybould, R, Redon, R, Reinders, MJT, Richard, AC, Riedel-Heller, SG, Rivadeneira, F, Rousseau, S, Ryan, NS, Saad, S, Sanchez-Juan, P, Schellenberg, GD, Scheltens, P, Schott, JM, Seripa, D, Seshadri, S, Sie, D, Sistermans, EA, Sorbi, S, van Spaendonk, R, Spalletta, G, Tesi, N, Tijms, B, Uitterlinden, AG, van der Lee, SJ, Visser, PJ, Wagner, M, Wallon, D, Wang, LS, Zarea, A, Clarimon, J, van Swieten, JC, Greicius, MD, Yokoyama, JS, Cruchaga, C, Hardy, J, Ramirez, A, Mead, S, van der Flier, WM, van Duijn, CM, Williams, J, Nicolas, G, Bellenguez, C, Lambert, JC. Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's disease. NATURE GENETICS. 2022; 54(12)DOI:10.1038/s41588-022-01208-7. PMID:36411364. IF:30.800(Q1/1D).
30/11/2022
beta-Synuclein as a candidate blood biomarker for synaptic degeneration in Alzheimer's disease
Mohaupt, P, Pons, ML, Vialaret, J, Delaby, C, Hirtz, C, Lehmann, S. beta-Synuclein as a candidate blood biomarker for synaptic degeneration in Alzheimer's disease. Alzheimers Research & Therapy. 2022; 14(1)DOI:10.1186/s13195-022-01125-1. PMID:36451155. IF:9.000(Q1/1D).
29/11/2022
Predicting AT(N) pathologies in Alzheimer's disease from blood-based proteomic data using neural networks
Zhang, YT, Ghose, U, Buckley, NJ, Engelborghs, S, Sleegers, K, Frisoni, GB, Wallin, A, Lleo, A, Popp, J, Martinez-Lage, P, Legido-Quigley, C, Barkhof, F, Zetterberg, H, Visser, PJ, Bertram, L, Lovestone, S, Nevado-Holgado, AJ, Shi, L. Predicting AT(N) pathologies in Alzheimer's disease from blood-based proteomic data using neural networks. Frontiers in Aging Neuroscience. 2022; 14DOI:10.3389/fnagi.2022.1040001. PMID:36523958. IF:4.800(Q2/3D).
01/09/2022
Neurofilaments: a key new biomarker for clinicians Part 1: Importance of neurofilaments in the management of neurodegenerative diseases
Delaby, C, Bousiges, O, Bouvier, D, Fillee, C, Fourier, A, Mondesert, E, Nezry, N, Omar, S, Quadrio, I, Rucheton, B, Schraen-Maschke, S, van Pesch, V, Vicca, S, Lehmann, S, Bedel, A. Neurofilaments: a key new biomarker for clinicians Part 1: Importance of neurofilaments in the management of neurodegenerative diseases. ANNALES DE BIOLOGIE CLINIQUE. 2022; 80(5)DOI:10.1684/abc.2022.1757. PMID:36453742. IF:0.500(Q4/10D).
01/09/2022
Neurofilaments: a key new biomarker for clinicians Part 2: Neurofilaments, an asset beyond neurodegenerative diseases
Delaby, C, Bousiges, O, Bouvier, D, Fillee, C, Fourier, A, Mondesert, E, Nezry, N, Omar, S, Quadrio, I, Rucheton, B, Schraen-Maschke, S, van Pesch, V, Vicca, S, Lehmann, S, Bedel, A. Neurofilaments: a key new biomarker for clinicians Part 2: Neurofilaments, an asset beyond neurodegenerative diseases. ANNALES DE BIOLOGIE CLINIQUE. 2022; 80(5)DOI:10.1684/abc.2022.1758. PMID:36453743. IF:0.500(Q4/10D).
01/09/2022
Exploring Links Between Psychosis and Frontotemporal Dementia Using Multimodal Machine Learning Dementia Praecox Revisited
Koutsouleris, N, Pantelis, C, Velakoulis, D, McGuire, P, Dwyer, DB, Urquijo-Castro, MF, Paul, R, Sen Dong, Popovic, D, Oeztuerk, O, Kambeitz, J, Salokangas, RKR, Hietala, J, Bertolino, A, Brambilla, P, Upthegrove, R, Wood, SJ, Lencer, R, Borgwardt, S, Maj, C, Nothen, M, Degenhardt, F, Polyakova, M, Mueller, K, Villringer, A, Danek, A, Fassbender, K, Fliessbach, K, Jahn, H, Kornhuber, J, Landwehrmeyer, B, Anderl-Straub, S, Prudlo, J, Synofzik, M, Wiltfang, J, Riedl, L, Diehl-Schmid, J, Otto, M, Meisenzahl, E, Falkai, P, Schroeter, ML, Lleo A., Int FTD-Genetics Consortium IFGC, German Frontotemporal Lobar Degene. Exploring Links Between Psychosis and Frontotemporal Dementia Using Multimodal Machine Learning Dementia Praecox Revisited. JAMA Psychiatry. 2022; 79(9)DOI:10.1001/jamapsychiatry.2022.2075. PMID:35921104. IF:25.800(Q1/1D).
23/05/2022
Prion-like alpha-synuclein pathology in the brain of infants with Krabbe disease
Hatton, C, Ghanem, SS, Koss, DJ, Abdi, IY, Gibbons, E, Guerreiro, R, Bras, J, Walker, L, Gelpi, E, Heywood, W, Outeiro, TF, Attems, J, McFarland, R, Forsyth, R, El-Agnaf, OM, Erskine, D, LLEO BISA, ALBERTO, Int DLB Genetics Consortium. Prion-like alpha-synuclein pathology in the brain of infants with Krabbe disease. BRAIN. 2022; 145(4)DOI:10.1093/brain/awac002. PMID:34999780. IF:14.500(Q1/1D).
01/03/2022
Focal Point The crucial history of Down syndrome
Zaman, S, Fortea, J. Focal Point The crucial history of Down syndrome. LANCET NEUROLOGY. 2022; 21(3)DOI:10.1016/S1474-4422(22)00047-3. PMID:35182507. IF:48.000(Q1/1D).
01/01/2022
Quality of Life and the Experience of Living with Early-Stage Alzheimer's Disease
Villarejo-Galende, A, Garcia-Arcelay, E, Pinol-Ripoll, G, del Olmo-Rodriguez, A, Vinuela, F, Boada, M, Franco-Macias, E, de la Pena, AI, Riverol, M, Puig-Pijoan, A, Abizanda-Soler, P, Arroyo, R, Baquero-Toledo, M, Feria-Vilar, I, Balasa, M, Berbel, A, Rodriguez-Rodriguez, E, Vieira-Camposs, A, Garcia-Ribas, G, Rodrigo-Herrero, S, Terrancle, A, Prefasi, D, Lleo, A, Maurino, J. Quality of Life and the Experience of Living with Early-Stage Alzheimer's Disease. JOURNAL OF ALZHEIMERS DISEASE. 2022; 90(2)DOI:10.3233/JAD-220696. PMID:36155523. IF:4.000(Q2/4D).
01/01/2022
Glutamate receptor 4 as a fluid biomarker for the diagnosis of psychiatric disorders
Gómez de San José N., Goossens J., Al Shweiki M.R., Halbgebauer S., Oeckl P., Steinacker P., Danzer K.M., Graf H., Schönfeldt-Lecuona C., Belbin O., Lleó A., Vanmechelen E., Otto M.. Glutamate receptor 4 as a fluid biomarker for the diagnosis of psychiatric disorders. JOURNAL OF PSYCHIATRIC RESEARCH. 2022; 156DOI:10.1016/j.jpsychires.2022.10.010. PMID:36323141. IF:4.800(Q2/4D).
01/01/2022
CSF proteome profiling across the Alzheimer’s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels
del Campo M., Peeters C.F.W., Johnson E.C.B., Vermunt L., Hok-A-Hin Y.S., van Nee M., Chen-Plotkin A., Irwin D.J., Hu W.T., Lah J.J., Seyfried N.T., Dammer E.B., Herradon G., Meeter L.H., van Swieten J., Alcolea D., Lleó A., Levey A.I., Lemstra A.W., Pijnenburg Y.A.L., Visser P.J., Tijms B.M., van der Flier W.M., Teunissen C.E.. CSF proteome profiling across the Alzheimer’s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels. Nature Aging. 2022; 2(11)DOI:10.1038/s43587-022-00300-1. PMID:37118088. IF:(Q/D).
01/01/2022
Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma
Valle-Tamayo N., Pérez-González R., Chiva-Blanch G., Belbin O., Serrano-Requena S., Sirisi S., González A.C., Giró O., Sánchez-Aced É., Dols-Icardo O., Alcolea D., Carmona-Iragui M., Jimenez A., Lleó A., Fortea J., Iulita M.F.. Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma. Jove-Journal of Visualized Experiments. 2022; 2022(186)DOI:10.3791/64107. PMID:35993755. IF:1.200(Q3/8D).
01/01/2022
Leveraging large multi-center cohorts of Alzheimer disease endophenotypes to understand the role of Klotho heterozygosity on disease risk
Ali M., Sung Y.J., Wang F., Fernández M.V., Morris J.C., Fagan A.M., Blennow K., Zetterberg H., Heslegrave A., Johansson P.M., Svensson J., Nellgård B., Lleó A., Alcolea D., Clarimon J., Rami L., Molinuevo J.L., Suárez-Calvet M., Morenas-Rodríguez E., Kleinberger G., Haass C., Ewers M., Levin J., Farlow M.R., Perrin R.J., Cruchaga C.. Leveraging large multi-center cohorts of Alzheimer disease endophenotypes to understand the role of Klotho heterozygosity on disease risk. PLoS One. 2022; 17DOI:10.1371/journal.pone.0267298. PMID:35617280. IF:3.700(Q2/4D).
01/01/2022
Smoking is associated with age at disease onset in Parkinson's disease
Rosas I., Morís G., Coto E., Blázquez-Estrada M., Suárez E., García-Fernández C., Martínez C., Herrera I.D., Pérez-Oliveira S., Álvarez V., Menéndez-González M., Adarmes-Gómez A.D., Aguilar M., Alvarez I., Barrero F.J., Bergareche Yarza J.A., Bonilla-Toribio M., Botía J.A., Boungiorno M.T., Buiza-Rueda D., Cámara A., Carrillo F., Cerdan D., Clarimón J., Compta Y., Diez-Fairen M., Dols-Icardo O., de Fabregues O., Cartagena P.S., Duarte J., Duran R., Escamilla-Sevilla F., Ezquerra M., Feliz C., Fernández-Santiago R., Fernández M., García-Ruiz P., Gómez-Garre P., Gomez Heredia M.J., Gonzalez-Aramburu I., Gorostidi A., Hoenicka J., Infante J., Jesús S., Jimenez-Escrig A., Kulisevsky J., Labrador-Espinosa M.A., Lopez-Sendon J.L., López de Munain A., Macias-Garcia D., Martínez-Torres I., Marín J., Marti M.J., Martínez-Castrillo J.C., Álvarez-Santullano M.M., Mínguez-Castellanos A., Mir P., Rezola E.M., Muñoz E., Pagonabarraga J., Pastor P., Errazquin F.P., Periñán M.T., Ruiz-Martínez J., Ruz C., Rodriguez A.S., Sierra M., Tabernero C., Tartari J.P., Tolosa E., Valldeoriola F., Vela L., Vives F., Pascual-Sedano B., Hernández-Vara J., Rolán D.V., Bandrés-Ciga S.. Smoking is associated with age at disease onset in Parkinson's disease. PARKINSONISM & RELATED DISORDERS. 2022; 97DOI:10.1016/j.parkreldis.2022.03.005. PMID:35364453. IF:4.100(Q2/3D).
01/12/2025
Linking genomic and proteomic signatures to brain amyloid burden: insights from GR@ACE/DEGESCO
Puerta, R, de Rojas, I, García-González, P, Olivé, C, Sotolongo-Grau, O, García-Sánchez, A, García-Gutiérrez, F, Montrreal, L, Tartari, JP, Sanabria, A, Pytel, V, Lage, C, Quintela, I, Aguilera, N, Rodriguez-Rodriguez, E, Alarcón-Martín, E, Orellana, A, Pastor, P, Pérez-Tur, J, Piñol-Ripoll, G, de Munain, AL, García-Alberca, JM, Royo, JL, Bullido, MJ, Alvarez, V, Real, LM, Anchuelo, AC, Gómez-Garre, D, Larrad, MTM, Franco-Macías, E, Mir, P, Medina, M, Sánchez-Valle, R, Dols-Icardo, O, Sáez, ME, Carracedo, A, Tárraga, L, Alegret, M, Valero, S, Marquié, M, Boada, M, Juan, PS, Cavazos, JE, Cabrera-Socorro, A, Cano, A, Ruiz, A, Alzheimers Dis Neuroimaging Initiative. Linking genomic and proteomic signatures to brain amyloid burden: insights from GR@ACE/DEGESCO. FUNCTIONAL & INTEGRATIVE GENOMICS. 2025; 25(1)DOI:10.1007/s10142-025-01581-6. PMID:40133566. IF:3.100(Q2/4D).
15/11/2025
Effects of radiofrequency electromagnetic fields on cognitive function in elderly subjects (60+years)-Results of an experimental randomized sham controlled double-blind cross-over study in women and in men
Sauter, C, Dorn, H, Bueno-Lopez, A, Eggert, T, Schmid, G, Danker-Hopfe, H. Effects of radiofrequency electromagnetic fields on cognitive function in elderly subjects (60+years)-Results of an experimental randomized sham controlled double-blind cross-over study in women and in men. ENVIRONMENTAL RESEARCH. 2025; 285DOI:10.1016/j.envres.2025.122479. PMID:40744201. IF:7.700(Q1/1D).
02/09/2025
An overview of the rivastigmine 13.3 mg/24h transdermal patch as a treatment option for Alzheimer's disease
Fortea, J, Ferrer-Picón, E. An overview of the rivastigmine 13.3 mg/24h transdermal patch as a treatment option for Alzheimer's disease. Expert Review of Neurotherapeutics. 2025; 25(9)DOI:10.1080/14737175.2025.2527211. PMID:40600688. IF:3.400(Q2/3D).
01/08/2025
Impaired cerebrospinal fluid lipoprotein-mediated cholesterol transport in Alzheimer's disease
Querol, CB, Canyelles, M, Santos, D, Martínez, J, Mercer, A, Zhao, Q, Rotllan, N, Núñez, E, Vázquez, J, Maspoch, D, Cano-Sarabia, M, Carmona-Iragui, M, Sirisi, S, Lleó, A, Fortea, J, Alcolea, D, Blanco-Vaca, F, Escolà-Gil, JC, Tondo, M. Impaired cerebrospinal fluid lipoprotein-mediated cholesterol transport in Alzheimer's disease. ATHEROSCLEROSIS. 2025; 407DOI:. PMID:. IF:5.700(Q1/1D).
22/07/2025
CHIT1 and DDAH1 levels relate to amyloid-related imaging abnormalities risk profile in Alzheimer's disease patients
Oosthoek, M, Vijverberg, EGB, Blujdea, ER, Veld, SGJGI, Avilés, MP, Zsadanyi, SE, Hok-A-Hin, YS, Visser, A, van der Flier, WM, Barkhof, F, del Campo, M, Schut, MC, Bejanin, A, Alcolea, D, Teunissen, CE, Vermunt, L. CHIT1 and DDAH1 levels relate to amyloid-related imaging abnormalities risk profile in Alzheimer's disease patients. Alzheimers Research & Therapy. 2025; 17(1)DOI:10.1186/s13195-025-01799-3. PMID:40696469. IF:7.600(Q1/1D).
05/07/2025
Prospective evaluation of plasma pTau217 stability for the detection of Alzheimer's disease in a tertiary memory clinic
Arranz, J, Ferrer, R, Zhu, NL, Rubio-Guerra, S, Rodríguez-Baz, I, Arriola-Infante, JE, Maure-Blesa, L, Garcia-Castro, J, Selma-González, J, Carmona-Iragui, M, Barroeta, I, Illán-Gala, I, Santos-Santos, M, Fortea, J, Lleó, A, Tondo, M, Alcolea, D. Prospective evaluation of plasma pTau217 stability for the detection of Alzheimer's disease in a tertiary memory clinic. Alzheimers Research & Therapy. 2025; 17(1)DOI:10.1186/s13195-025-01779-7. PMID:40618130. IF:7.600(Q1/1D).
03/07/2025
Cortical macro- and microstructural changes in isolated rapid eye movement sleep behavior disorder
Pardo, J, Roura, I, Montal, V, Martin-Barcelo, C, Oltra, J, Campabadal, A, Bargallo, N, Serradell, M, Maya, G, Montini, A, Gaig, C, Pont-Sunyer, C, Fortea, J, Iranzo, A, Junqué, C, Segura, B. Cortical macro- and microstructural changes in isolated rapid eye movement sleep behavior disorder. npj Parkinsons Disease. 2025; 11(1)DOI:10.1038/s41531-025-01058-0. PMID:40610447. IF:8.200(Q1/1D).
01/07/2025
Comparative performance of plasma pTau181/Aß42 , pTau217/Aß42 ratios, and individual measurements in detecting brain amyloidosis
Lehmann, S, Gabelle, A, Duchiron, M, Busto, G, Morchikh, M, Delaby, C, Hirtz, C, Mondesert, E, Cristol, JP, Barnier-Figue, G, Perrein, F, Jurici, S, Bennys, K. Comparative performance of plasma pTau181/Aß42 , pTau217/Aß42 ratios, and individual measurements in detecting brain amyloidosis. EBioMedicine. 2025; 117DOI:10.1016/j.ebiom.2025.105805. PMID:40513421. IF:10.800(Q1/1D).
01/07/2025
Transferability of European-derived Alzheimer's disease polygenic risk scores across multiancestry populations
Nicolas, A, Sherva, R, Grenier-Boley, B, Kim, Y, Kikuchi, M, Timsina, J, de Rojas, I, Dalmasso, MC, Zhou, XP, Le Guen, Y, Arboleda-Bustos, CE, Bicalho, MAC, Guerchet, M, van der Lee, S, Goss, M, Castillo, A, Bellenguez, C, Küçükali, F, Satizabal, CL, Fongang, B, Yang, Q, Peters, O, Schneider, A, Dichgans, M, Rujescu, D, Scherbaum, N, Deckert, J, Riedel-Heller, S, Hausner, L, Molina-Porcel, L, Duezel, E, Grimmer, T, Wiltfang, J, Heilmann-Heimbach, S, Moebus, S, Tegos, T, Scarmeas, N, Dols-Icardo, O, Moreno, F, Pérez-Tur, J, Bullido, MJ, Pastor, P, Sánchez-Valle, R, Alvarez, V, Cao, H, Ip, NY, Fu, AKY, Ip, FCF, Olivar, N, Muchnik, C, Cuesta, C, Campanelli, L, Solis, P, Politis, DG, Kochen, S, Brusco, LI, Boada, M, García-González, P, Puerta, R, Mir, P, Real, LM, Pinol-Ripoll, G, García-Alberca, JM, Royo, JL, Rodriguez-Rodriguez, E, Soininen, H, Heikkinen, S, de Mendonça, A, Mehrabian, S, Traykov, L, Hort, J, Vyhnalek, M, Rasmussen, KL, Thomassen, JQ, Pijnenburg, YAL, Holstege, H, van Swieten, JC, Seelaar, H, Claassen, JAHR, Jansen, WJ, Ramakers, I, Verhey, F, van der Lugt, A, Scheltens, P, Ortega-Rojas, J, Mera, AGC, Mahecha, MF, Pardo, R, Arboleda, G, Bahrami, S, Fominykh, V, Selbaek, G, Graff, C, Papenberg, G, Giedraitis, V, Boland, A, Deleuze, JF, de Marco, LA, de Moraes, EN, Viana, BD, Cintra, MTG, Juarez-Cedillo, T, Griswold, AJ, Forund, T, Haines, J, Farrer, L, Destefano, A, Wijsman, E, Mayeux, R, Pericak-Vance, M, Kunkle, B, Goate, A, Schellenberg, GD, Vardarajan, B, Wang, LS, Leung, YY, Dalgard, CL, Nicolas, G, Wallon, D, Dufouil, C, Pasquier, F, Hanon, O, Debette, S, Gruenblatt, E, Popp, J, Angel, B, Gloger, S, Chacon, MV, Aranguiz, R, Orellana, P, Slachevsky, A, Gonzalez-Billault, C, Albala, C, Fuentes, P, Sachdev, P, Mather, KA, Hauger, RL, Merritt, V, Panizzon, M, Zhang, R, Gaziano, JM, Ghidoni, R, Galimberti, D, Arosio, B, Mecocci, P, Solfrizzi, V, Parnetti, L, Squassina, A, Tremolizzo, L, Borroni, B, Nacmias, B, Caffarra, P, Seripa, D, Rainero, I, Daniele, A, Piras, F, Leonard, HL, Yokoyama, JS, Nalls, MA, Miyashita, A, Hara, N, Ozaki, K, Niida, S, Williams, J, Masullo, C, Amouyel, P, Preux, PM, Mbelesso, P, Bandzouzi, B, Saykin, A, Jessen, F, Kehoe, PG, Van Duijn, C, Ben Salem, N, Frikke-Schmidt, R, Cherni, L, Greicius, MD, Tsolaki, M, Sánchez-Juan, P, Silva, MAR, Porter, T, Laws, SM, Sleegers, K, Ingelsson, M, Dartigues, JF, Seshadri, S, Rossi, G, Morelli, L, Hiltunen, M, Sims, R, van der Flier, W, Andreassen, OA, Arboleda, H, Cruchaga, C, Escott-Price, V, Ruiz, A, Lee, KH, Ikeuchi, T, Ramirez, A, Gim, J, Logue, M, Lambert, JC. Transferability of European-derived Alzheimer's disease polygenic risk scores across multiancestry populations. NATURE GENETICS. 2025; 57(7)DOI:10.1038/s41588-025-02227-w. PMID:40533518. IF:29.000(Q1/1D).
01/06/2025
Democratizing dementia research through global online conferences
Zsadanyi, SE, Addison, E, Alladi, S, Andrews, SJ, Keerthana, BS, Carello-Collar, G, Dubljevic, O, Ehrenberg, AJ, Farina, FR, Grinberg, LT, Ibáñez, A, Martersteck, A, Nigussie, A, Rogalski, EJ, Seibert, K, Stefanova, E, Yaffe, K, Zewde, YZ, Zimmer, ER, Fontana, IC, Sexton, CE. Democratizing dementia research through global online conferences. NATURE NEUROSCIENCE. 2025; 28(6)DOI:10.1038/s41593-025-01949-8. PMID:40325214. IF:20.000(Q1/1D).
01/06/2025
Use of Multiple Languages Provides Cognitive Reserve Amidst Age-Related White Matter Changes
Solé-Padullés, C, Cattaneo, G, Cabello-Toscano, M, Mulet-Pons, L, Vaqué-Alcázar, L, Roca-Ventura, A, Alviarez-Schulze, V, Bargalló, N, Solana-Sánchez, J, Pascual-Leone, A, Bartrés-Faz, D. Use of Multiple Languages Provides Cognitive Reserve Amidst Age-Related White Matter Changes. JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES. 2025; 80(6)DOI:10.1093/geronb/gbaf064. PMID:40197522. IF:3.200(Q1/1D).
30/05/2025
SARS-CoV-2 infection of human cortical cells is influenced by the interaction between aneuploidy and biological sex: insights from a Down syndrome in vitro model
Lioudyno, MI, Sevrioukov, EA, Olivarria, GM, Hitchcock, L, Javonillo, DI, Campos, SM, Rivera, I, Wright, ST, Head, E, Fortea, J, Wisniewski, T, Cuello, AC, Do Carmo, S, Lane, TE, Busciglio, J. SARS-CoV-2 infection of human cortical cells is influenced by the interaction between aneuploidy and biological sex: insights from a Down syndrome in vitro model. ACTA NEUROPATHOLOGICA. 2025; 149(1)DOI:10.1007/s00401-025-02895-2. PMID:40445428. IF:9.300(Q1/1D).
24/05/2025
Regulatory asymmetry in Alzheimer's disease care
Fortea, J, Boban, M, Engelborghs, S, Frederiksen, KS, Hort, J, Kennelly, S, Kramberger, MG, Mehrabian, S, Plantone, D, Paquet, C, Santana, I, Scarmeas, N, Solje, E, Spiru, L, Sutovsky, S, Vijverberg, EGB, Winblad, B, Jessen, F. Regulatory asymmetry in Alzheimer's disease care. LANCET. 2025; 405(10492)DOI:10.1016/S0140-6736(25)00907-9. PMID:40381642. IF:88.500(Q1/1D).
09/05/2025
Reduced blood EPAC1 protein levels as a marker of severe coronary artery disease: the role of hypoxic foam cell-transformed smooth muscle cells
Garcia, E, Claudi, L, Lhoëst, MTL, Polishchuk, A, Samouillan, V, Amaro, AB, Pinero, J, Escolà-Gil, JC, Sabidó, E, Leta, R, Vilades, D, Cortes, VL. Reduced blood EPAC1 protein levels as a marker of severe coronary artery disease: the role of hypoxic foam cell-transformed smooth muscle cells. Journal of Translational Medicine. 2025; 23(1)DOI:10.1186/s12967-025-06513-3. PMID:40346550. IF:7.500(Q1/2D).
01/05/2025
LRP1 immunotherapy enhances cardiomyocyte respiration by restricting cholesteryl ester accumulation in mitochondria
Benitez-Amaro, A, Garcia, E, Lhoëst, MTL, Polishchuk, A, Zegri-Reiriz, I, Vilades, D, Guerra, JM, Fernández-del-Rio, L, Mirabet, S, Samouillan, V, Shirihai, O, Liesa, M, Enrich, C, Llorente-Cortés, V. LRP1 immunotherapy enhances cardiomyocyte respiration by restricting cholesteryl ester accumulation in mitochondria. JOURNAL OF LIPID RESEARCH. 2025; 66(5)DOI:10.1016/j.jlr.2025.100783. PMID:40122209. IF:4.100(Q2/4D).
01/05/2025
Relationship of cognitive decline with glucocerebrosidase activity and amyloid-beta 42 in DLB and PD
Gonzalez, MC, Oftedal, L, Lange, J, Tovar-Rios, DA, Tysnes, OB, Paquet, C, Marquie, M, Boada, M, Alcolea, D, Rejdak, K, Papuc, E, Hort, J, Falup-Pecurariu, C, Aarsland, D, Alves, G, Maple-Grodem, J. Relationship of cognitive decline with glucocerebrosidase activity and amyloid-beta 42 in DLB and PD. Annals of Clinical and Translational Neurology. 2025; 12(5)DOI:10.1002/acn3.52295. PMID:40051075. IF:3.900(Q1/3D).
05/04/2025
Advancing Personalized Medicine in Alzheimer's Disease: Liquid Biopsy Epigenomics Unveil APOE e4-Linked Methylation Signatures
Macías, M, Alba-Linares, JJ, Acha, B, Blanco-Luquin, I, Fernández, AF, Alvarez-Jiménez, J, Urdánoz-Casado, A, Roldan, M, Robles, M, Cabezon-Arteta, E, Alcolea, D, de Gordoa, JSR, Corroza, J, Cabello, C, Erro, ME, Jericó, I, Fraga, MF, Mendioroz, M. Advancing Personalized Medicine in Alzheimer's Disease: Liquid Biopsy Epigenomics Unveil APOE e4-Linked Methylation Signatures. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025; 26(7)DOI:10.3390/ijms26073419. PMID:40244264. IF:4.900(Q1/3D).